"We have communicated with Solventum, who makes this software, and they have made changes based on our feedback," says Timothy D. Lyon, MD. Investigators recently identified key concerns in the US ...

Experts discuss how they communicate various treatment options for non–muscle-invasive bladder cancer (NMIBC) with patients and health care professionals.

Experts share their initial impressions of the available data on immunotherapies, including PD-L1 inhibitors durvalumab and sasanlimab, being evaluated in bacille Calmette-Guérin (BCG)–unresponsive ...

FG-3246 demonstrated promising clinical activity and manageable safety in a phase 1 trial for mCRPC, with a maximum tolerated dose of 2.7 mg/kg every three weeks. Notable adverse events included ...

"We must lobby to maintain our current funding levels and push for increased support to continue driving progress in cancer care," says Michael S. Cookson, MD, MMHC, FACS. “Healthy citizens are the ...

High interreader and intrareader agreement rates were found, especially in newly diagnosed prostate cancer patients, supporting 18F-Flotufolastat's FDA approval. Lower agreement rates in the ...

“If it is as efficacious as it looks, we will have more patients who are getting effective standard of care treatment, not needing to go on to further treatment, not having recurrences, [having ...

Jack R. Andrews, MD; Eugene B. Cone MD; and Edwin Posadas, MD, FACP, discuss how early intervention with individualized treatment approaches based on disease volume, patient characteristics, and ...

"I say with a lot of confidence, just continue using telehealth as you are," says Chad Ellimoottil, MD, MS. The policy environment surrounding telehealth is a volatile one, according to Chad ...

"They are risking their own lives for their job, so it's the part of the whole community to do our best to try to keep them safe," says Sima P. Porten, MD, MPH. Firefighters face an increased risk of ...

"I'm all for this great effort by ImmunityBio to provide us with an alternative option,” says Suzanne B. Merrill, MD, FACS. For years, urologists and patients have dealt with the effects of the BCG ...

The Glean Urodynamics System offers wireless, catheter-free monitoring, improving accuracy and comfort for LUTD patients. Developed with Cleveland Clinic, the system allows natural voiding, enhancing ...